Q1 2026 net revenue growth year-over year for Acute Care franchise (+32%), including ZYNRELEF® (+27%) and APONVIE® (+50%)Q1 ...

Q1 2026 net revenue growth year-over year for Acute Care franchise (+32%), including ZYNRELEF- (+27%) and APONVIE- (+50%)Q1 2026 total net revenue of $34.7 millionReached settlement with Baxter Health ...

Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage AI-driven precision oncology company leveraging its proprietary RADR ® artificial intelligence (AI) and machine learning (ML) platform to transform ...

A key sticking point to greater adoption of biosimilar medications by health plans are lawsuits from brand manufacturers ...

Genomics and Harvard University have sued Element Biosciences, alleging that Element’s AVITI24™ multiomics platform, Teton ...

A new year brings a fresh Fierce Biotech Fundraising Tracker designed to record the significant amount of venture capital that flows into biopharma. We’re keeping the same guidelines used for last ...

Genetically engineered cultured host cells containing recombinant nucleic acids useful for gene therapy are patent-eligible for being ...

Welcome to Fierce Biotech’s fifth annual layoff tracker, a resource designed to keep pace with the sector’s steady stream of workforce reductions. In 2025, industry layoffs continued to rise year over ...

Wolf, Greenfield & Sacks is one of the largest US law firms exclusively focused on IP, representing a wide range of clients from startups and universities to Fortune 500 companies. The firm has a ...

Discover the latest in biotechnology with press releases highlighting innovations, research, and developments driving biotech's future. Stay informed on advancements changing biotech and explore ...